The established function of thyroid stimulating hormone (TSH) is to promote thyroid follicle
development and hormone secretion. The osteoporosis associated with hyperthyroidism is …

Postmenopausal osteoporosis, a global public health problem, has for decades been attributed
solely to declining estrogen levels. Although FSH levels rise sharply in parallel, a direct …

Alzheimer’s disease has a higher incidence in older women, with a spike in cognitive decline
that tracks with visceral adiposity, dysregulated energy homeostasis and bone loss during …

Menopause is associated with bone loss and enhanced visceral adiposity. A polyclonal
antibody that targets the β-subunit of the pituitary hormone follicle-stimulating hormone (Fsh) …

We report that oxytocin (OT), a primitive neurohypophyseal hormone, hitherto thought solely
to modulate lactation and social bonding, is a direct regulator of bone mass. Deletion of OT …

In nonneuronopathic type 1 Gaucher disease (GD1), mutations in the glucocerebrosidase
gene (GBA1) gene result in glucocerebrosidase deficiency and the accumulation of its …

There is a common mechanism for mechanotransduction in cells, regardless of the cell type.
Integrins, interacting with their matrix/environment, mediate increases in intracellular Ca 2+ …

We describe the effects of the overexpression of noggin, a bone morphogenetic protein (BMP)
inhibitor, on osteoblast differentiation and bone formation. Cells of the osteoblast and …

Declining estrogen production after menopause causes osteoporosis in which the resorption
of bone exceeds the increase in bone formation. We recently found that mice deficient in …

We report that adrenocorticotropic hormone (ACTH) protects against osteonecrosis of the
femoral head induced by depot methylprednisolone acetate (depomedrol). This therapeutic …